Business ❯Healthcare ❯Pharmaceuticals ❯Drug Development

Clinical Trials

Novo Nordisk's Amycretin Shows 22% Weight Loss in Trial, Boosting Stock

AbbVie Stock Plummets After Schizophrenia Drug Trials Fail

Summit Therapeutics' Lung Cancer Drug Outperforms Merck's Keytruda in Trial

Roche Accelerates Development of Promising Weight-Loss Pills